Abstract:Background: To support high rates of protein synthesis, pancreatic acinar cells must generate large quantities of ATP. Mitochondrial dysfunction and impaired energy metabolism play a significant role in the development of pancreatitis. Patients with elevated plasma triglycerides are at increased risk for development of severe acute pancreatitis. Carnitine palmitoyltransferase II (CPT2) is required for importing and thus metabolizing long-chain fatty acids (LCFAs) in mitochondria. To inhibit LCFA metabolism, we utilized the CPT2 acinarKO mouse to probe the consequences of impaired LCFA import on pancreatic function. Hypothesis: Loss of CPT2 causes an accumulation of long-chain acylcarnitines and disruption of the tissue acylcarnitine/free carnitine ratio which is thought to alter cellular function. Given acinar cells’ high metabolic requirement, impaired LCFA utilization would reduce energy production, secretory function, and alter pancreatic lipid composition. Methods: We generated mice lacking CPT2 specifically in acinar cells (CPT2 acinarKO ) by crossing tamoxifen-inducible, Elastase-Cre mice with CPT2 floxed mice. Mice were fed a high fat (60% kcal fat), low fat (10% kcal fat), or chow (14% kcal fat) diet for 12 weeks. Analysis of fat accumulation, edema, and fibrosis was performed with H&E and picrosirius staining. Mass Spec. lipid profiling was performed in pancreas and serum. Acinar cells were isolated from wildtype, CPT2 floxed, and CPT2 acinarKO mice to assess secretory function, ATP levels, and necrosis via lactate dehydrogenase (LDH) release. Results: Histologic examination revealed CPT2 acinarKO mice on all three diets displayed pancreatic fat accumulation. Strikingly, CPT2 acinarKO mice fed a chow or low fat diet developed chronic pancreatitis with a 25% loss in pancreatic weight, immune cell infiltration, edema, and fibrosis. As anticipated, long-chain acylcarnitines were significantly elevated in CPT2 acinarKO pancreas. Assessment of secretion in 2 weeks post tamoxifen cells revealed significantly reduced maximal (10 pM) and supramaximal (1 nM) cholecystokinin (CCK) stimulated amylase release as a percent of total cellular amylase. Acini isolated at 4 weeks post tamoxifen revealed significantly increased basal secretion and reduced maximal and supramaximal CCK stimulated amylase release. When normalized to cellular DNA, secretion was similar between CPT2 acinarKO and CPT2 floxed acinar cells indicating CPT2 acinarKO cells had reduced amylase levels. Wildtype acinar cells treated with unsaturated and saturated free fatty acid concentrations as low as 100 μM for 3 hours caused significant necrosis. CPT2 acinarKO pancreas had significantly decreased ATP levels indicative of mitochondrial dysfunction. Conclusion: Loss of CPT2 in the pancreatic acinar cells impairs LCFA import, reduces ATP levels, disrupts the secretory pathway, promoting chronic pancreatitis. In contrast to other CPT2 knockout models, pancreatitis occurs independent of high fat feeding in CPT2 acinarKO mice. Further investigation is needed to identify metabolic alterations leading to acinar damage and mitochondrial dysfunction following the loss of CPT2. UW-Madison Comprehensive Diabetes Center Pilot Grant. This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

The genetic risk factor CEL-HYB1 causes proteotoxicity and chronic pancreatitis in mice

The CEL-HYB1 Hybrid Allele Promotes Digestive Enzyme Misfolding and Pancreatitis in Mice

Preclinical mouse model of a misfolded PNLIP variant develops chronic pancreatitis

Human CPA1 mutation causes digestive enzyme misfolding and chronic pancreatitis in mice

Secreted cyclophilin A levels elevate in animal models and patients with acute pancreatitis at disease early stage

No Association Between CEL-HYB Hybrid Allele and Chronic Pancreatitis in Asian Populations.

Overexpression of Interleukin-1Beta in the Murine Pancreas Results in Chronic Pancreatitis.

Trypsin Activity Governs Increased Susceptibility to Pancreatitis in Mice Expressing Human PRSS1R122H

Modeling protease-sensitive human pancreatic lipase mutations in the mouse ortholog

ASIC — LIVER , PANCREAS , AND BILIARY RACT verexpression of Interleukin-1 in the Murine Pancreas Results in hronic Pancreatitis

A common CTRB misfolding variant associated with pancreatic cancer risk causes ER stress and inflammation in mice

Impaired Long-Chain Fatty Acid Metabolism in Carnitine Palmitoyltransferase II Knockout Mouse Leads to Chronic Pancreatitis

320 - A Novel Genetic Model of Progressive Chronic Pancreatitis Caused by Impairment of the Endoplasmic Reticulum Acetyl-COA Transporter AT-1

Helicase-like transcription factor (Hltf)-deletion activates Hmgb1-Rage axis and granzyme A-mediated killing of pancreatic β cells resulting in neonatal lethality

Lipoprotein Lipase Gene-Deficient Mice with Hypertriglyceridaemia Associated with Acute Pancreatitis.

Heterozygous Spink1 C.194+2t>c Mutation Promotes Chronic Pancreatitis after Acute Attack in Mice

Impaired TFEB-mediated Lysosomal Biogenesis Promotes the Development of Pancreatitis in Mice and is Associated with Human Pancreatitis.

Protease-Sensitive Pancreatic Lipase Variants Are Associated with Early Onset Chronic Pancreatitis

Exploring the enigmatic association between PNLIP variants and risk of chronic pancreatitis in a large Chinese cohort

Haploid Insufficiency of Suppressor Enhancer Lin12 1-Like (SEL1L) Protein Predisposes Mice to High Fat Diet-Induced Hyperglycemia.

Loss of Acinar Cell VMP1 Triggers Spontaneous Pancreatitis in Mice